Multiple Myeloma
Showing NaN - NaN of 56
Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)
Not yet recruiting
- Multiple Myeloma
- idecabtagene vicleucel
- +3 more
-
Gilbert, Arizona
- +107 more
Sep 26, 2023
Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)
Recruiting
- Multiple Myeloma
-
Benowa, Queensland, Australia
- +132 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (JNJ-68284528, Pomalidomide, Bortezomib)
Active, not recruiting
- Multiple Myeloma
- JNJ-68284528
- +4 more
-
Birmingham, Alabama
- +87 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)
Active, not recruiting
- Multiple Myeloma
- Dara SC
- Dara IV
-
Boston, Massachusetts
- +145 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)
Real-life Current Standards of Care in Relapsed and/or
Completed
- Multiple Myeloma
- No intervention
-
Tucson, Arizona
- +85 more
Dec 20, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib 20 mg/m^2
- +4 more
-
Gilbert, Arizona
- +107 more
Dec 20, 2022
Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- bb2121
- +8 more
-
Birmingham, Alabama
- +59 more
Dec 13, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
-
New Port Richey, Florida
- +94 more
Nov 30, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +139 more
Sep 9, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
-
Woolloongabba, Queensland, Australia
- +117 more
Aug 3, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +34 more
Jul 22, 2022
Multiple Myeloma Trial in Worldwide (PHE885)
Recruiting
- Multiple Myeloma
- PHE885
-
VIC, Melbourne, Australia
- +4 more
Jul 20, 2022
Multiple Myeloma Trial in Worldwide (bb2121)
Active, not recruiting
- Multiple Myeloma
- bb2121
-
San Francisco, California
- +47 more
Jul 18, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Tucson, Arizona
- +131 more
Jul 1, 2022